Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is a group of inherited blood disorders that have in common a mutation in the sixth codon of the β-globin (HBB) gene on chromosome 11.
|
27022141 |
2016 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Genetic variants at three quantitative trait loci (QTL) for fetal haemoglobin (HbF), BCL11A, HBS1L-MYB and the β-globin gene cluster, have attracted interest as potential targets of therapeutic strategies for HbF reactivation in sickle cell anaemia (SCA).
|
29879141 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is caused by a monogenic mutation of the β-globin gene and affects millions of people worldwide.
|
31015205 |
2019 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
|
16004608 |
2005 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is a recessive genetic disorder caused by a single-nucleotide polymorphism in the β-globin gene (HBB).
|
27733558 |
2016 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Because the expression of normally silenced fetal ɣ-type globin genes and resultant production of fetal hemoglobin (HbF) in adult erythroid cells can ameliorate the pathophysiological consequences of both abnormal β-globin chains in sickle cell anemia and deficient β-globin chain production in β-thalassemia, understanding the complex mechanisms of this developmental switch has direct translational clinical relevance.
|
24880147 |
2015 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Globally, sickle cell disease (SCD) is one of the commonest severe monogenic disorders, due to the inheritance of two abnormal haemoglobin (beta globin) genes.
|
30067867 |
2018 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
To assess alpha+-thalassemia deletion alleles, beta-thalassemia mutations and haplotypes linked to the HBB*S cluster in a sample of 130 unrelated sickle cell anemia (SCA) patients (55% female) from Belém, Pará State, for their possible effects on the patients' survival.
|
20737602 |
2011 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
For optimal benefit, reversion of the point mutation in HBB leading to sickle cell disease (SCD) would permit precise homology-directed repair (HDR) while concurrently limiting on-target non-homologous end joining (NHEJ)-based HBB disruption.
|
31279229 |
2019 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
It is likely that determinants unrelated to haplotype, linked or unlinked to the beta-globin gene cluster, are the major effectors of differences in the levels of HbF in American patients with sickle cell anemia.
|
1996558 |
1991 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A significant level of correction of the mutation responsible for sickle cell anemia has been achieved in monkey COS-7 cells on a plasmid containing a beta-globin gene fragment.
|
16943853 |
2007 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors.
|
28689691 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Determination of beta-globin gene cluster haplotypes and prevalence of alpha-thalassemia in sickle cell anemia patients in Venezuela.
|
10814985 |
2000 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is caused by a mutation of the β-globin gene (Ingram VM.
|
30067082 |
2018 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
β-globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sβ⁰-thalassemia and their association with clinical and hematological features.
|
20938172 |
2010 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is characterized by a single point mutation in the seventh codon of the β-globin gene.
|
25733580 |
2015 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
While the addition of the wild-type beta-globin gene is naturally suited for treating beta-thalassemia, several alternatives have been proposed for the treatment of sickle cell disease, using either gamma or mutant beta-globin gene addition, trans-splicing or RNA interference.
|
16567956 |
2006 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease (SCD) is an autosomal recessive disorder caused by a mutation in β-globin (HBB) gene.
|
31255831 |
2019 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Nonisotopic M13 probes for detecting the beta-globin gene: application to diagnosis of sickle cell anemia.
|
3608154 |
1987 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Sickle cell disease is one of the commonest severe monogenic disorders in the world, due to the inheritance of two abnormal haemoglobin (beta globin) genes.
|
28094851 |
2017 |
Anemia, Sickle Cell
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.
|
20846340 |
2010 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
LHGDN |
DNAase I hypersensitive site 3' to the beta-globin gene cluster contains a TAA insertion specific for beta(S)-Benin haplotype.
|
11869935 |
2002 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
The stable introduction of a functional beta-globin gene in haematopoietic stem cells could be a powerful approach to treat beta-thalassaemia and sickle-cell disease.
|
10894546 |
2000 |
Anemia, Sickle Cell
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Some patients with sickle cell disease have exceptionally high levels of HbF that are associated with the Senegal and Saudi-Indian haplotype of the HBB-like gene cluster; some patients with different haplotypes can have similarly high HbF.
|
21490337 |
2011 |
Anemia, Sickle Cell
|
0.800 |
Biomarker
|
disease |
BEFREE |
Sickle cell anemia (SCA) and β -thalassemia major are well-recognized beta-globin gene disorders of red blood cells associated to mortality and morbidity included bone morbidities due to ineffective erythropoiesis and bone marrow expansion, which affect every part of the skeleton.
|
29447888 |
2018 |